BASEL, Switzerland (AP) — BASEL, Switzerland (AP) — Novartis AG (NVS) on Friday reported fourth-quarter net income of $2.82 billion. On a per-share basis, the Basel, Switzerland-based company said it ...

Novartis AG released its Annual Report for 2024, alongside its ‘Novartis in Society – Integrated Report 2024.’ This announcement underscores the company ...

TD Cowen analyst Steve Scala reiterated a Hold rating on Novartis (NVS – Research Report) today and set a price target of $125.00. The ...

UK], and AEE788 [Novartis, Basel, Switzerland]) inhibit more than one receptor in addition to EGFR, such as HER2 and VEGFR2. TKIs block ligand-induced receptor autophosphorylation by binding to ...

Novartis is one of the world's top pharmaceutical companies, and along with neighbours Roche, the mainstay of Switzerland's centuries-long contribution to new medicines. Headquartered in Basel ...

Real-time imaging shows that bacterial resilience to antibiotics is not caused by a few ‘persisters’, but is a ...

Joint research activities will be carried out at Novartis’ sites in Basel, Switzerland, and Dublin, Ireland, as well as at the Microsoft Research Lab in Cambridge, UK.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis was formed by the merger of Ciba-Geigy and Sandoz.